AusDiagnostics is proud to announce a new distribution partnership with BGI Americas (BGI) in the United States.
The non-exclusive distribution agreement will see BGI distribute AusDiagnostics Tandemplex® MT-PCR products throughout the United States. Tandemplex® panels allow users to efficiently detect and differentiate between numerous pathogens that cause similar symptoms. This provides healthcare professionals with comprehensive diagnostic information that supports decisions to deliver better patient care.
BGI Americas is a subsidiary of BGI Genomics, a leading provider of multi-omics solutions. This partnership will assist both AusDiagnostics and BGI to expand their footprint in molecular diagnostics to address the testing needs in the United States.
AusDiagnostics CEO, Scott Gilroy, said the union marks another significant step in AusDiagnostics’ global growth journey. “We are extremely proud to partner with BGI. Our key focus for 2022 has been to expand our sales and distribution network so we can better support our customers,” said Mr Gilroy. “We have a small and growing team on the ground in the United States and engaging with a strong industry leader like BGI will help us to accelerate the delivery of better testing solutions to our customers.”
AusDiagnostics COO, Nicole McKeown, said AusDiagnostics were thrilled to commence work with BGI. “The alliance is a positive move to enhance our customer experience by increasing accessibility of our portfolio throughout the market and delivering high-quality service through an expanded team of experts in the field.”
BGI’s Director of Corporate Development, Craig Hoechstetter, said that BGI Americas was excited to work with AusDiagnostics to provide additional products to their clinical customers in the United States. “We are confident that these products along with BGI’s own products will help customers to meet their clinical testing needs.”
AusDiagnostics are currently expanding the team in the United States with new career opportunities now available. For more information, please click here.
AusDiagnostics’ North American office is located in Dallas, Texas.
About AusDiagnostics:
AusDiagnostics Pty Ltd is a leading international company that designs, manufactures, and markets a comprehensive suite of multiplexing molecular diagnostic assays and reagents. Founded in August 2006, AusDiagnostics also supports robotic instruments for in vitro diagnostics in medical, veterinary, and applied testing. The company serves global customers through offices in Australia, New Zealand, the United Kingdom, and the United States. In 2018, AusDiagnostics opened a manufacturing facility in the United Kingdom to support the supply of products to its growing network of customers and distribution partners in more than 25 countries.
For further details, contact:
media@ausdx.com
+61 (02) 9698 8030